Dr. Ibrahim Al-Zakwani Associate Professor Head of Pharmacy, SQUH

advertisement
Dr. Ibrahim Al-Zakwani
Associate Professor
Head of Pharmacy, SQUH
Education:
PhD (Health Policy), University of the Sciences in Philadelphia, USA (2005)
MS (Health Policy), University of the Sciences in Philadelphia, USA (2002)
MSc (Clinical Pharmacy), Strathclyde University, Scotland, UK (1996)
MRPharmS, Membership of the Royal Pharmaceutical Society of Great Britain, UK
(1992)
BSc (Pharmacy), Strathclyde University, Scotland, UK (1991)
Contact details:
Room number: 1461
Office Tel.: 00968 24144420
Fax: 00968 24144430
E-mail: azakwani@squ.edu.om; ial_zakwani@yahoo.com
Research Interest:
 Pharmacoeconomics
 Health Outcome Research
Selected Publications:
1. Al-Rasadi K, Al-Zakwani I, Al Mahmeed W, Arafah M, Al-Hinai AT, Shehab
A, Al Tamimi O, Al Awadi M. Therapeutic lipid target achievements among
high and highest risk patients: Results from the CEPHEUS study in the
Arabian Gulf. Current Medical Research & Opinion 2014; 30 (12): 2429-35.
2. Zubaid M, Rashed W, Alsheikh-Ali AA, Al-Zakwani I, Al Mahmeed W,
Shehab A, Sulaiman K, Al Qudaimi A, Amin H. Management and 1 year
outcomes of atrial fibrillation in the Middle East: The observational Gulf
Survey of Atrial Fibrillation Events (Gulf SAFE). Angiology 2014. June 5.
pii: 0003319714536980. [Epub ahead of print]
3. Kumar A, Al-Bader M, Al-Thani H, El-Menyar A, Al Suwaidi J, Al-Zakwani
I, Deleu D. Multi center cross-study of asymptomatic peripheral artery disease
among patients with a single previous coronary or cerebrovascular event in the
Arabian Gulf. Current Medical Research & Opinion 2014; 30 (9): 1725-32.
4. Farhan H, Albulushi A, Taqi A, Al-Hashim A, Al-Saidi K, Al-Rasadi K, AlMazroui A, Al-Zakwani I. Incidence and pattern of thyroid dysfunction in
patients on chronic amiodarone therapy – experience at a tertiary care center in
Oman. The Open Cardiovascular Medicine Journal 2013; 7; 122-6.
5. Al-Balushi K, Qasim J, Al-Zakwani I. Comparative effectiveness of
irbesartan/HCTZ and valsartan/HCTZ combination in lowering blood
pressure: a retrospective observational study in Oman. Medical Principles and
Practice. 2013; 22 (3): 265-9.
Links:
PubMed, Google Scholar, Research Gate
Download